Sort by
Sort by
Ariel Kauss
Atieh Givmanesh

Harris Nami
Jasmine Roberts

Philip Tagari, Chief Scientific Officer


Philip Tagari, Chief Scientific Officer
Philip Tagari is currently Chief Scientific Officer of insitro, leading a team of multidisciplinary scientists and engineers who are redefining disease biology and implementing novel approaches to dramatically speed the delivery of meaningful therapeutics to patients with grievous disease. Prior to insitro, Philip spent a decade as Vice President of Research (Therapeutic Discovery) at Amgen Inc. During that time, his global teams advanced over 30 innovative molecules into clinical development and commercialization including Lumukras® (first-in-class KRASG12C inhibitor); Tarlatamab (DLL3 BiTE®); AMG133 (anti-obesity bispecific) and Efavaleukin alfa (AMG 592) a novel IL-2 mutein Fc fusion. He is a Director of CQDM (Consortium Quebecois sur la Decouverte du Medicament; Quebec Consortium for Drug Discovery) and SAB member for BenchSci (biology machine learning) and NutcrackeRx (mRNA therapeutics).
Prior to joining Amgen in 1998, Philip was a Research Fellow at Merck Frosst (Canada) Inc, where he contributed to the discovery of Singulair® and Vioxx®. Philip is a graduate of Gonville & Caius College, Cambridge University (UK), and performed neurobiology research using pioneering quantitative image analysis at McGill and Oxford Universities.
Rahul Atmaramani

Rahul Atmaramani
Selected Publications:
Adaptation of robust Z’factor for assay quality assessment in microelectrode array based screening using adult dorsal root ganglion neurons.
https://www.sciencedirect.com/science/article/abs/pii/S0165027020301229Adult mouse sensory neurons on microelectrode arrays exhibit increased spontaneous and stimulus-evoked activity in the presence of interleukin-6.
https://journals.physiology.org/doi/full/10.1152/jn.00158.2018Conserved expression of Nav1.7 and Nav1.8 contribute to the spontaneous and thermally evoked excitability in IL-6 and NGF-sensitized adult dorsal root ganglion neurons in vitro.
https://www.mdpi.com/2306-5354/7/2/44Keywords
All Departments, Therapeutic Areas,Robert Miller
Roey Baror

Roey Baror
Selected Publications:
Metformin Restores CNS Remyelination Capacity by Rejuvenating Aged Stem Cells
https://www.sciencedirect.com/science/article/pii/S1934590919303509Transforming growth factor‐beta renders ageing microglia inhibitory to oligodendrocyte generation by CNS progenitors
https://onlinelibrary.wiley.com/doi/full/10.1002/glia.23612Keywords
All Departments, Therapeutic Areas,Sam Sances

Sam Sances
Selected Publications:
iPSC modeling of young-onset Parkinson’s disease reveals a molecular signature of disease and novel therapeutic candidates
AH Laperle, S Sances, N Yucer, VJ Dardov, VJ Garcia, R Ho, AN Fulton, …
Nature Medicine 26 (2), 289-299
Google scholar
View articlesKeywords
All Departments, Therapeutic Areas,Tima Dehghani